Work for Tyme Technologies, Inc.?

Claim Your Profile

Tyme Technologies, Inc. Logo Image

Tyme Technologies, Inc.

Tyme Technologies, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2018 Annual Report and Form 10K

Tyme Technologies, Inc.

Annual
Report

Tyme Technologies, Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

  • Tyme Technologies, Inc.
  • Tyme Technologies, Inc.
  • Tyme Technologies, Inc.

About Tyme Technologies, Inc.

11-50 Employees
Based in New York City, New York

Tyme Technologies, Inc., is an emerging biotechnology company developing cancer metabolism-based therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.

Ticker:
TYME
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol